SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:liu-113301"
 

Search: onr:"swepub:oai:DiVA.org:liu-113301" > Individual variatio...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Individual variations in treatment decisions by Swedish rheumatologists regarding biological drugs for rheumatoid arthritis

Kalkan, Almina (author)
Linköpings universitet,Avdelningen för hälso- och sjukvårdsanalys,Hälsouniversitetet
Hallert, Eva (author)
Linköpings universitet,Avdelningen för hälso- och sjukvårdsanalys,Hälsouniversitetet
Carlsson, Per (author)
Linköpings universitet,Avdelningen för hälso- och sjukvårdsanalys,Hälsouniversitetet
show more...
Roback, Kerstin (author)
Linköpings universitet,Avdelningen för hälso- och sjukvårdsanalys,Hälsouniversitetet
Sjöwall, Christopher (author)
Linköpings universitet,Avdelningen för neuro- och inflammationsvetenskap,Medicinska fakulteten,Region Östergötland, Reumatologiska kliniken i Östergötland
show less...
 (creator_code:org_t)
Informa Healthcare, 2015
2015
English.
In: Scandinavian Journal of Rheumatology. - : Informa Healthcare. - 0300-9742 .- 1502-7732. ; 44:4, s. 265-270
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objective: In Sweden, reports indicate surprisingly large regional variation in prescription of biological drugs, despite a growing number of clinical studies describing their beneficial effects and guidelines by professional organizations and agencies. Our objective was to ascertain whether there is also variation between individual rheumatologists in prescribing biologics to patients with rheumatoid arthritis (RA) and to evaluate reasons for treatment choices.Methods: Ten hypothetical patient cases were constructed and presented to 26 rheumatologists in five regions in Sweden. The cases were based on actual cases and were thoroughly elaborated by a senior rheumatologist and pre-tested in a pilot study. The respondents were asked whether they would treat the patients with a biological agent (YES/NO) and to explain their decisions.Results: The response rate was 26/105; 25%. Treatment choices varied considerably between the rheumatologists, some prescribing biologics to 9/10 patients and others to 2/10. In five of the ten hypothetical cases, approximately half of the respondents would prescribe biologics. No regions with particularly high or low prescription were identified. Both the decision to prescribe biologics, as well as not to prescribe, were mainly motivated by medical reasons. Some rheumatologists also referred to lifestyle-related factors or social function of the patient.Conclusion: The choice of initiation of biologics varied substantially among rheumatologists presented with hypothetical patient cases, and there were also disparities between rheumatologists practising at the same clinic. Treatment choices were primarily motivated by medical reasons. This situation raises concerns about a lack of consensus in RA treatment strategies.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Find more in SwePub

By the author/editor
Kalkan, Almina
Hallert, Eva
Carlsson, Per
Roback, Kerstin
Sjöwall, Christo ...
About the subject
MEDICAL AND HEALTH SCIENCES
MEDICAL AND HEAL ...
and Clinical Medicin ...
Articles in the publication
Scandinavian Jou ...
By the university
Linköping University

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view